Oakland or Fremont Appliance, Air Conditioning and Heating Repair

AmpliPhis novel bacteriophage therapy demonstrates comparable efficacy to vancomycin in S.

AmpliPhi’s novel bacteriophage therapy demonstrates comparable efficacy to vancomycin in S. Aureus lung illness model Results presented at the Joint Interscience Conference of Antimicrobial Brokers and Chemotherapy and International Congress of Chemotherapy and Infection 2015 conference AmpliPhi Biosciences Company , a worldwide leader in the development of bacteriophage-based antibacterial therapies to take care of drug-resistant infections, today announced experimental results highlighting that its prototype bacteriophage cocktail demonstrated comparable efficacy to vancomycin in reduced amount of Staphylococcus aureus in a murine lung illness model. Data from this scholarly study, performed in collaboration with the Hearts Consulting Group and the University of North Texas Wellness Science Center, were presented at the joint Interscience Conference of Antimicrobial Brokers and Chemotherapy and International Congress of Chemotherapy and An infection 2015 meeting, from September 17-21 occurring in San Diego levitra online .